Prestige Brands Holdings, Inc. — Form 10-Q Summary
Business context and reporting period
The filing covers the quarter and nine months ended December 31, 2011, in the company’s fiscal year ending March 31, 2012. Prestige Brands Holdings markets and distributes OTC healthcare and household cleaning products, primarily in the U.S. and Canada. Its reportable segments are OTC Healthcare and Household Cleaning.
Financial performance and liquidity
| Metric | Three months ended Dec. 31, 2011 | Nine months ended Dec. 31, 2011 |
|---|---|---|
| Total revenue | $106.3 million, up 17.3% | $307.1 million, up 27.9% |
| Gross profit / margin | $55.1 million / 51.9% | $158.9 million / 51.7% |
| Operating income | $23.6 million | $80.3 million |
| Net income | $9.5 million; diluted EPS $0.19 | $37.2 million; diluted EPS $0.73 |
| Cash from operations | Not reported for the quarter | $48.0 million |
For comparison, prior-year revenue was $90.6 million and $240.1 million, net income was $2.2 million and $22.8 million, and nine-month operating cash flow was $61.7 million. Nine-month diluted EPS was $0.45 in the prior year. The nine-month gross margin edged down from 51.9%; quarterly margin rose from 48.6%. Nine-month operating cash flow declined $13.7 million year over year, which management attributed mainly to higher working-capital needs, interest payments and incentive compensation.
At December 31, cash was $4.4 million, current assets $105.9 million and current liabilities $53.1 million. Debt principal was $434.0 million, down from $492.0 million at March 31 after $58.0 million of voluntary repayments; the net carrying amount was $429.6 million. The company reported $40.0 million of revolving-credit availability and $75.0 million of incremental term-loan capacity, and said it was in compliance with debt covenants. Nine-month investing activities provided $0.8 million, while financing activities used $57.7 million. No dividend had been declared or paid.
Material changes versus prior periods
- OTC Healthcare revenue rose 25.9% in the quarter and 44.3% for nine months. Acquired Blacksmith and Dramamine products contributed $16.6 million of quarterly and $68.7 million of nine-month revenue growth cited by management.
- Household Cleaning revenue fell 7.8% in the quarter and 6.9% for nine months, mainly reflecting weaker Comet sales. Household Cleaning gross margin fell to 26.0% for the quarter and 29.0% for nine months.
- Quarterly operating income increased to $23.6 million from $13.0 million. Lower G&A versus the prior-year quarter reflected $6.9 million of Blacksmith-related transaction and severance costs in that comparison period, partly offset by $4.9 million of current-period acquisition costs.
- Nine-month interest expense rose to $25.0 million from $18.5 million, reflecting higher average debt and borrowing costs. The nine-month net income comparison also includes a $5.1 million pretax settlement gain in 2011; the gain was not from ongoing operations.
Outlook, management commentary, risks and unusual items
Management estimated a 38.7% effective tax rate for the remaining quarter of fiscal 2012, excluding discrete items; it did not provide broader earnings or revenue guidance in this filing. Management described advertising, product extensions, distribution gains and acquisitions as growth levers, while noting pressure in Comet and some OTC brands.
After quarter-end, on January 31, 2012, the company completed its acquisition of 15 GSK OTC brands for $615 million. It expected to complete the purchase of two additional brands for $45 million by June 30, 2012, completing the announced $660 million transaction. To fund the acquisition and related needs, the company issued $250 million of 8.125% notes due 2020 and entered into a $660 million, seven-year term-loan facility and a $50 million, five-year asset-based revolver; it also repaid the prior term loan. The filing does not provide post-closing debt balances or final purchase-price allocations.
Key risks include customer concentration (one customer represented 20.9% of quarterly gross revenue and 23.4% of receivables), reliance on third-party manufacturers and a major distribution center, competitive and commodity-cost pressures, acquisition integration and debt service. Goodwill and intangible assets totaled $932.9 million, and management cautioned that adverse changes in sales, margins, competition or consumer preferences could prompt future impairment. No impairment was recorded for the reported periods. A Trutek arbitration panel denied all claims against the company on January 30, 2012. The filing also reports $4.9 million of GSK-related costs expensed during the quarter and nine-month period.
Important facts for investors to verify
- How much of reported revenue and earnings growth reflects acquisitions versus organic performance, particularly given weaker Household Cleaning results.
- Post-GSK acquisition debt, borrowing costs, covenant headroom and available liquidity; the filing gives financing terms but not a complete post-closing balance sheet.
- Whether cash generation recovers from the nine-month decline amid increased working-capital requirements and acquisition-related spending.
- Customer and supplier concentration, and performance of Comet and other brands facing weaker demand or competitive pressure.
- The sustainability of reported earnings excluding the $5.1 million settlement gain and acquisition-related expenses, and the sensitivity of goodwill and intangible valuations to operating assumptions.